A Nutritional Supplement as Adjuvant of Gabapentinoids for Adults with Neuropathic Pain following Spinal Cord Injury and Stroke: Preliminary Results

Gabapentinoids are first choice drugs for central neuropathic pain (CNP) despite limited evidence of efficacy and side effects affecting therapy outcomes. Nutraceuticals could improve their efficacy and tolerability. Our aim is to investigate the effect of NACVAN(®), in addition to gabapentinoids, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffaeli, William, Felzani, Giorgio, Tenti, Michael, Greco, Luca, D’Eramo, Maria Pia, Proietti, Stefania, Morone, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531277/
https://www.ncbi.nlm.nih.gov/pubmed/37761760
http://dx.doi.org/10.3390/healthcare11182563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531277/
https://www.ncbi.nlm.nih.gov/pubmed/37761760
http://dx.doi.org/10.3390/healthcare11182563

Ejemplares similares